PATENT CLAIM ANALYSIS

Application Number: 15892302
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "212070"]

Abstract:
The present disclosure is concerned with benzo annulene compounds that are capable of inhibiting a viral infection and methods of treating viral infections such as, for example, chikungunya, Venezuelan equine encephalitis, dengue, influenza, and zika, using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Claim (Index 8):
The compound of  claim 1 , wherein Cy 1  is C4-C5 heteroaryl substituted with 0, 1, or 2 groups independently selected from halogen, \u2014CO 2 H, \u2014CN, \u2014OH, \u2014NH 2 , C1-C8 alkyl, C1-C8 haloalkyl, C1-C8 alkylnitrile, C1-C8 hydroxyalkyl, C1-C8 alkoxy, C1-C8 halohydroxyalkyl, C1-C8 aminoalkyl, C1-C8 alkylamino, (C1-C8)(C1-C8) dialkylamino, Cy 1 , and Ar 3 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.42308
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14380659', '14913266', '15039763', '15283508', '13329025']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7988217722404783
- 35 USC 102 Novelty (BERT): 0.5628702175953358
- Combined Prediction Score: 0.7752266167759642
- Mean Citation Score: 415.690416
- Max Citation Score: 428.13474
- Similarity Product: 359.5612838583327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test